DERMTECH
DermTech develops and commercializes qPCR assays for skin samples collected non-invasively using adhesive tape biopsy methods. The Company’s assays can analyze multiple gene targets to assess their level of RNA expression. The Company anticipates providing these assays through a CLIA certified laboratory located in San Diego. The Company will initially offer an assay for pigmented skin lesions sampled using an adhesive tape collection method. The Company has identified gene targets differentially expressed in melanoma samples (British Journal of Dermatology, April 2011). This assay can assess RNA expression consistent with melanoma with very high sensitivity (>95%) and specificity (>70%).
DERMTECH
Industry:
Beauty Biotechnology Genetics Health Care Health Diagnostics
Founded:
1996-01-01
Address:
La Jolla, California, United States
Country:
United States
Website Url:
http://www.dermtech.com
Total Employee:
101+
Status:
Active
Contact:
(858) 450-4222
Total Funding:
259.86 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics Global Site Tag Mobile Non Scaleable Content Sitelinks Search Box
Similar Organizations
Bionano Genomics
BioNano Genomics develops nanoscale imaging and analytic platforms designed to analyze DNA and other genome-related peptides and proteins.
Bluebird Bio
Bluebird Bio offers products based on the transformative potential of gene therapy for patients with genetic and orphan diseases.
Cofactor Genomics
Cofactor Genomics builds multidimensional models of disease to deliver true precision medicine.
Human Longevity
Human Longevity is a genomic-based, health intelligence company empowering proactive healthcare and enabling a life better lived.
Intarcia Therapeutics
Intarcia Therapeutics develops therapies for diseases that require long-term chronic treatment.
NeoGenomics
NeoGenomics is a cancer reference laboratory that provides cancer testing and partnership programs to pathologists and oncologists.
Radius Health
Radius Health develops drug therapies for osteoporosis and women’s health.
CareDx
CareDx is a novel molecular diagnostics company.
Current Employees Featured
John Dobak Founder & CEO @ DermTech
Founder & CEO
2013-12-01
Burkhard Jansen Chief Medical Officer @ DermTech
Chief Medical Officer
2013-07-01
James Rock Vice President of Clinical Operations and Research Contracts @ DermTech
Vice President of Clinical Operations and Research Contracts
2017-03-01
Claudia Ibarra Chief Operating Officer @ DermTech
Chief Operating Officer
2019-11-01
Kevin Sun Chief Financial Officer,Treasurer, Secretary @ DermTech
Chief Financial Officer,Treasurer, Secretary
2019-08-01
Sarah Dion Vice President Product Strategy @ DermTech
Vice President Product Strategy
Todd Wood Chief Commercial Officer @ DermTech
Chief Commercial Officer
2019-01-01
Adelle Walker Vice President, Consumer Products @ DermTech
Vice President, Consumer Products
2022-02-01
Daniel Visage Senior Vice President, Payer Access @ DermTech
Senior Vice President, Payer Access
2019-11-01
Zuxu Yao Chief Technology Officer @ DermTech
Chief Technology Officer
2017-02-01
Founder
Stock Details
Investors List
HLM Venture Partners
HLM Venture Partners investment in Venture Round - DermTech
Tech Coast Angels
Tech Coast Angels investment in Venture Round - DermTech
Key Employee Changes
| Date | New article |
|---|---|
| 2022-07-28 | DermTech Appoints Chief Compliance Officer and SVP of Research and Development |
| 2022-02-23 | DermTech Welcomes Adelle Walker as Vice President of Consumer Products |
Official Site Inspections
http://www.dermtech.com Semrush global rank: 1.01 M Semrush visits lastest month: 33.76 K
- Host name: 80.189.82.34.bc.googleusercontent.com
- IP address: 34.82.189.80
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "DermTech"
Leadership | DermTech
Burkhard Jansen, M.D., is the President of DermTech, LLC, where he leads the company’s efforts on strategy and stakeholder outreach to serve the dermatology community and its patients through non-invasive genomic testing for skin …See details»
About Us - DermTech
Feb 25, 2022 DermTech’s mission is to improve the lives of millions by providing non-invasive precision dermatology solutions that enable individualized care.See details»
DermTech - Crunchbase Company Profile & Funding
DermTech develops and commercializes qPCR assays for skin samples using adhesive tape biopsy methods.See details»
DermTech, Inc. - AnnualReports.com
DermTech is the leading genomics company in dermatology and is creating a new category of medicine, precision dermatology, enabled by their non …See details»
DermTech, LLC - LinkedIn
DermTech, LLC provides genomic analysis of skin samples collected non-invasively using its Smart Stickers. DermTech develops and markets products to facilitate the assessment of melanoma.See details»
DermTech (DMTKQ) Company Profile & Description - Stock Analysis
2 days ago Company profile for DermTech, Inc. (DMTKQ) with a description, list of executives, contact details and other key facts.See details»
DermTech - Org Chart, Teams, Culture & Jobs | The Org
View DermTech's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
DermTech's Leadership Team Team - Team members and org …
The leadership team at DermTech has experience in the medical and aesthetics industries, as well as sales.See details»
DermTech Company Profile - Office Locations, Competitors ... - Craft
Aug 28, 2024 DermTech has 1 employees at their 1 location and $15.3 m in annual revenue in FY 2023. See insights on DermTech including office locations, competitors, revenue, …See details»
Dermtech Canada Inc Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Dermtech Canada Inc of Vancouver, BC. Get the latest business insights from Dun & Bradstreet.See details»
Board of Directors | DermTech
Jim is the Chairman of DermTech, LLC, where he leads the company’s executive team in serving the dermatology community and its patients through non-invasive genomic testing for skin …See details»
DermTech Inc company information, history, management and …
DermTech Inc is an emerging growth molecular diagnostic company. The company is engaged in marketing and developing novel non-invasive genomic tests to aid in the diagnosis of various …See details»
DermTech Completes Transaction for Asset Sale; Operations …
Aug 30, 2024 SAN DIEGO– (BUSINESS WIRE)–DermTech, Inc. (OTC: DMTKQ) (DermTech or the Company) a leader in precision dermatology offering non-invasive skin genomics …See details»
Dermtech files for Chapter 11, lays off 20% of staff
Jun 20, 2024 Dive Brief: Dermtech has filed for Chapter 11 bankruptcy protection and laid off 20% of its staff to support its push to find a buyer for its cancer test technology, the company …See details»
DermTech - Funding, Financials, Valuation & Investors
DermTech develops and commercializes qPCR assays for skin samples using adhesive tape biopsy methods.See details»
Health Tech Company Hopes To Transform Skin Cancer Testing In …
Aug 30, 2022 John Dobak got a medical degree. But decided to go the entrepreneurial route. In 2015, he started DermTech, a company that uses a sticker to test for skin cancer. "There's too …See details»
Mission, Vision & Core Values of DermTech
Dec 19, 2024 DermTech is a pioneering company at the forefront of revolutionizing skin cancer diagnostics through non-invasive methods. Our mission is to provide accurate and early …See details»
Dermtech Files Chapter 11 Bankruptcy, Cuts 15 Employees
Jun 24, 2024 Dermtech, a skin cancer diagnostic company, recently announced it has filed for Chapter 11 bankruptcy after months of looking for strategic alternatives. Additionally, the news …See details»
DermTech Files for Bankruptcy to Restructure Debt and Sell Assets
Jul 9, 2024 The organization's workforce was reduced by half to approximately 75 employees during the most recent round in April. DermTech recently submitted documents to the …See details»